AstraZeneca’s year-end revenues rise but Wall Street remains unimpressed

AstraZeneca’s year-end revenues rise but Wall Street remains unimpressed

Submitted by admin on February 8, 2024 - 11:23am
Source: 
Medical Marketing and Media
News Tags: 
AstraZeneca
earnings
COVID-19
Headline: 
AstraZeneca’s year-end revenues rise but Wall Street remains unimpressed
snippet: 

Like so many drugmakers, the waning demand for COVID-19 products hampered the bottom line, with AstraZeneca notching a $3.7 billion decline in revenue from COVID products over the year.

Do Not Allow Advertisers to Use My Personal information